In its new classification of central nervous system tumors, the World Health Organization (WHO) refers to IDH-mutant GB as grade 4 mutated IDH astrocytoma to distinguish more clearly between this entity and non-mutated IDH GB [16,17]. The gene discussed is IDH1; the disease is central nervous system cancer.